Kingston Anne Evans sold $65K of PRTA
Kingston Anne Evans (Chief Strategy Officer) sold 7,662 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.47 on 2026-07-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which generally limits bearish inference.
Market read
Traders may note the insider sale, but the 10b5-1 structure suggests limited incremental information for valuation.
What to watch
The article does not provide context on total insider holdings, tax/vesting needs, or whether other insiders sold or bought around the same time.
Background
The article is a SEC Form 4 insider transaction disclosure for Prothena Corp Public Ltd Co (PRTA).
Ticker impact
Prothena disclosed an insider open-market sale by Chief Strategy Officer Kingston Anne Evans of 7,662 shares at $8.4729 on 2026-07-29.
Likely minimal, unless traders overinterpret insider selling as bearish.
The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
No sector read-through is provided beyond a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider sales under a 10b5-1 plan can be purely liquidity-driven and may not reflect a change in company outlook.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Subject of the Form 4 insider transaction disclosure.
- insiderKingston Anne Evans
Chief Strategy Officer who sold 7,662 shares in an open-market transaction.
